|
|
||||||||
-induced cytoskeletal alterations in endothelial cells
The Dorrance Hamilton Research Laboratories, 1Division of Nephrology, 2Division of Endocrinology, Department of Medicine, 3Department of Physiology, Thomas Jefferson University, Philadelphia, Pennsylvania
Submitted 21 January 2005 ; accepted in final form 6 May 2005
Cytoskeletal alterations in endothelial cells have been linked to nitric oxide generation and cell-cell interactions. Transforming growth factor (TGF)-
has been described to affect cytoskeletal rearrangement in numerous cell types; however, the underlying pathway is unclear. In the present study, we found that human umbilical vein endothelial cells (HUVEC) have marked cytoskeletal alterations with short-term TGF-
treatment resulting in filipodia formation and F-actin assembly. The cytoskeletal alterations were blocked by the novel TGF-
type I receptor/ALK5 kinase inhibitor (SB-505124) but not by the p38 kinase inhibitor (SB-203580). TGF-
also induced marked stimulation of reactive oxygen species (ROS) within 5 min of TGF-
exposure. TGF-
stimulation of ROS was mediated by the NAPDH oxidase homolog Nox4 as DPI, an inhibitor of NADPH oxidase, and dominant-negative Nox4 adenovirus blocked ROS production. Finally, inhibition of ROS with ROS scavengers or dominant-negative Nox4 blocked the TGF-
effect on cytoskeleton changes in endothelial cells. In conclusion, our studies show for the first time that TGF-
-induced ROS production in human endothelial cells is via Nox4 and that TGF-
alteration of cytoskeleton in HUVEC is mediated via a Nox4-dependent pathway.
human umbilical vein endothelial cells; cell-cell interactions; cytoskeletal rearrangement; transforming growth factor-
This article has been cited by other articles:
![]() |
C. Xia, Q. Meng, L.-Z. Liu, Y. Rojanasakul, X.-R. Wang, and B.-H. Jiang Reactive Oxygen Species Regulate Angiogenesis and Tumor Growth through Vascular Endothelial Growth Factor Cancer Res., November 15, 2007; 67(22): 10823 - 10830. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Orient, A. Donko, A. Szabo, T. L. Leto, and M. Geiszt Novel sources of reactive oxygen species in the human body Nephrol. Dial. Transplant., May 1, 2007; 22(5): 1281 - 1288. [Full Text] [PDF] |
||||
![]() |
K. Bedard and K.-H. Krause The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology Physiol Rev, January 1, 2007; 87(1): 245 - 313. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Moldovan, K. Mythreye, P. J. Goldschmidt-Clermont, and L. L. Satterwhite Reactive oxygen species in vascular endothelial cell motility. Roles of NAD(P)H oxidase and Rac1 Cardiovasc Res, July 15, 2006; 71(2): 236 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Geiszt NADPH oxidases: New kids on the block Cardiovasc Res, July 15, 2006; 71(2): 289 - 299. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |